Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Hepatitis

  Free Subscription


08.12.2025

1 Am J Gastroenterol
1 Gut
1 J Infect Dis
2 J Med Virol
3 J Viral Hepat
1 JAMA
2 Lancet
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. CHEN CH, Tai WC, Hu TH, Wang JH, et al
    Patterns of Hepatitis B Virus Viremia Change and Hepatitis B Surface Antigen Loss Rate in Patients Without Retreatment Within 2 Years After Entecavir or Tenofovir Cessation.
    Am J Gastroenterol. 2025;120:2832-2839.
    PubMed         Abstract available


    Gut

  2. CHU CM, Liaw YF
    Nucleos(t)ide analogue therapy for EASL immune-tolerant phase hepatitis B.
    Gut. 2025 Dec 3:gutjnl-2025-337558. doi: 10.1136/gutjnl-2025-337558.
    PubMed        


    J Infect Dis

  3. GHORBANI M, Kvedaraite A, Al-Manei K, Too CB, et al
    Oral Microbiome Diversity Matters on Nucleos(t)ide Analogue Cessation in Chronic Hepatitis B.
    J Infect Dis. 2025 Dec 2:jiaf591. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  4. LIN Z, Zhang X, Lai Y, Tong X, et al
    Glomerulonephritis, the Most Common Extrahepatic Manifestation Caused by Hepatitis B Virus Infection: Possible Pathogenesis and Therapeutic Approaches.
    J Med Virol. 2025;97:e70731.
    PubMed         Abstract available

  5. DIAGNE MM, Fall G, Sall A, Sow B, et al
    Molecular Characterization of Rift Valley Fever Virus From the 2025 Outbreak in Northern Senegal Reveals Lineage H Persistence and Key Polymerase Mutations.
    J Med Virol. 2025;97:e70734.
    PubMed         Abstract available


    J Viral Hepat

  6. LI X, Liao C, Gu Y, Lian Y, et al
    Immune Checkpoints Determine the NK/NKT and T Cell Immunity in Chronic Hepatitis B.
    J Viral Hepat. 2026;33:e70108.
    PubMed         Abstract available

  7. SIVAKUMAR H, Dhodapkar R, Chinnakali P, Philomenadin FS, et al
    Understanding the Serologic and Molecular Epidemiology of Hepatitis A Infection in Puducherry and Surrounding Regions of India.
    J Viral Hepat. 2026;33:e70104.
    PubMed         Abstract available

  8. TAYE B, Valery P, Ananta S, Kc S, et al
    Modelling Micro-Elimination: Third-Trimester Tenofovir Prophylaxis for Perinatal Transmission of Hepatitis B in the Remote Dolpa District of Nepal.
    J Viral Hepat. 2026;33:e70110.
    PubMed         Abstract available


    JAMA

  9. ABERS MS, Ulrich AK, Walensky RP
    Universal Hepatitis B Vaccination at Birth-Risks of Revising the Recommendation.
    JAMA. 2025 Dec 3. doi: 10.1001/jama.2025.24996.
    PubMed        


    Lancet

  10. COOKE GS, Walker SA, Barnes E, Thwaites G, et al
    HCV response-guided therapy: is shorter always better? - Authors' reply.
    Lancet. 2025;406:2540.
    PubMed        

  11. XU L, Zhao W
    HCV response-guided therapy: is shorter always better?
    Lancet. 2025;406:2539-2540.
    PubMed        


    PLoS One

  12. HELIKUMI M, Mushanyu J, Mhlanga A
    A mathematical model of HCV transmission dynamics with sex stratification and environmental effects.
    PLoS One. 2025;20:e0336374.
    PubMed         Abstract available

  13. NDLOVU NL, Scheibe A, Hausler H, Sonderup MW, et al
    Factors associated with phylogenetic clustering of hepatitis C virus, mainly among people who inject drugs who access HIV prevention services in South Africa, 2016-2017.
    PLoS One. 2025;20:e0336614.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  14. IWASAKI W, Kashiwagi K, Sakamoto A, Nishimoto M, et al
    Structural insights into the role of eIF3 in translation mediated by the HCV IRES.
    Proc Natl Acad Sci U S A. 2025;122:e2505538122.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.